USPTO serial 76520690
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Hiroshima-shi, Hiroshima, JP
Hiroshima-shi, Hiroshima, JP
Hiroshima-shi, Hiroshima, JP
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William L. Androlia
WILLIAM L ANDROLIA KODA & ANDROLIA2029 CENTURY PARK E STE 1430LOS ANGELES, CA 90067UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals namely, manufactured cells for medical or research uses; chemicals for use in diagnosis and therapy; chemical additives for use in manufacture of foods, drugs and cosmetics; chemicals for cell culturing; chemical preparations for cell therapy and medicines; chemicals for detection of cells and their products; chemicals for medical detection or quantitation of normal cells or cancer cells in living body; chemical solutions for cell storage; chemicals for detection of genes, DNA and RNA; chemicals for diagnosis or detection of minute substances from living body samples; DNA, proteins and their preparations for medical or research uses; high-molecular-weight molecule structures embedded in living body; plastics raw materials namely polyurethane and derivatives thereof; and polymeric material for use in cell segregation | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceuticals namely pharmaceutical wafers, media for cell culturing, pharmaceutical preparations for treatment of leukemia, cancers, cirrhosis, neurodegenerative diseases, heart attacks, strokes, rheumatoid arthritis, diabetes mellitus, allergic diseases, autoimmune diseases, endocrine diseases, vessel diseases, inflammatory diseases, infectious diseases, and congenital gene defects | SECTION 8 - CANCELLED | — |
| 009 | Physics and chemistry equipment and instruments for use in regenerative medicines; optical equipment and instruments namely microscopes for detection and observation of cells; measurement equipment and instruments namely apparatus for measuring cell sizes and cell colony sizes; batteries namely biological and chemical batteries; electric instruments namely apparatus for cell culturing and monitoring; applied electronic equipment and instruments and parts therefor namely apparatus for detection of expression profile of cellular proteins and DNA, apparatus for detection of physical or chemical characteristics of cells, apparatus for detection of cancer cells, apparatus for detection of minute substances from living body samples, apparatus for cell culturing, apparatus for cell manipulation, apparatus for cell freezing and storage and cell injection apparatus | SECTION 8 - CANCELLED | — |
| 010 | Medical equipment and instruments namely apparatus for cell separation, apparatus for cell analysis, apparatus for monitoring of cell proliferation and condition, apparatus for detection of cultured cell or cells, culture apparatus and medical apparatus for cell merchandise and stem cell merchandise, plastic bags for use in blood transfusion, freeze-up bags for medical use, injection needles, disposable plastic consumption articles for medical use | SECTION 8 - CANCELLED | — |
| 042 | Product research, design and testing for others of genes and proteins; product safety testing of machines or instruments used in medical research; computer program design for others, and rental of physics and chemistry equipment | SECTION 8 - CANCELLED | — |
| 044 | Provision of medical information; health examinations including cell therapies, administration of high-molecular-weight molecule structures, processing of cells for cell therapies, and storing and banking of frozen cells of umbilical cord blood, bone marrow and peripheral blood; rental of medical equipment | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 14, 2015 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Sep 21, 2006 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Feb 2, 2005 | PAPER RECEIVED | — | |
| Jan 11, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 19, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 29, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 25, 2004 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 20, 2004 | ALIE | ASSIGNED TO LIE | — |
| Aug 17, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 17, 2004 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 2, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 21, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2004 | PAPER RECEIVED | — | |
| Jan 27, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 19, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2003 | PAPER RECEIVED | — |